Socioeconomic disparities and life's essential 8: a focused review and considerations for improving cardiovascular health in the United States - Report - MDSpire

Socioeconomic disparities and life's essential 8: a focused review and considerations for improving cardiovascular health in the United States

  • By

  • Vikas Sunder

  • Jennifer Garrow

  • Erik Van Iterson

  • Kardie Tobb

  • Nichole Opet

  • Sandra Tsai

  • Emelia Asamoah

  • Parveen Garg

  • Aniruddha Singh

  • Juliana Namutebi

  • Oby Ibe

  • Mansi Patil

  • Traci Mitchell

  • Keith Ferdinand

  • July 15, 2026

Share

Clinical Report: Addressing Socioeconomic Inequities and Life's Essential 8

Overview

This review discusses the impact of socioeconomic disparities on cardiovascular health in the U.S. and identifies strategies for clinicians to enhance care for patients of low socioeconomic status using the American Heart Association's Life's Essential 8 framework.

Background

Cardiovascular disease remains the leading cause of death in the U.S., with socioeconomic status significantly influencing health outcomes. The Life's Essential 8 framework outlines key domains for improving cardiovascular health, emphasizing the need for interdisciplinary collaboration among healthcare providers. Addressing socioeconomic disparities is crucial for enhancing screening, treatment, and overall cardiovascular outcomes.

Data Highlights

Key findings indicate that socioeconomic disparities lead to gaps in cardiovascular screening and care, and that lower socioeconomic status increases the risk of recurrent cardiovascular events independent of risk factors.

Key Findings

  • Socioeconomic disparities lead to persistent gaps in cardiovascular screening and care.
  • Lower socioeconomic status increases the risk of recurrent cardiovascular events independent of risk factors.
  • The AHA's PREVENT risk calculator incorporates social deprivation indices to assess cardiovascular risk.
  • Resources for clinicians to address socioeconomic barriers exist but are often fragmented.
  • Improving communication and utilizing community resources can enhance patient care for those with low SES.

Clinical Implications

Clinicians should utilize available resources to improve cardiovascular health for patients of low socioeconomic status, incorporating social determinants of health into patient assessments.

Conclusion

Addressing socioeconomic inequities is essential for improving cardiovascular health outcomes in the U.S. The Life's Essential 8 framework provides a structured approach for clinicians to enhance care for vulnerable populations.

Related Resources & Content

  1. European Journal of Preventive Cardiology, 2025 -- Fundamental Eight Factors in Preventing Cardiovascular Disease
  2. European Journal of Preventive Cardiology, 2025 -- Gender-related differences in adolescents’ cardiovascular health detected with the Life’s Essential 8 score
  3. European Journal of Preventive Cardiology, 2025 -- The positive impact of the Life's Essential 8 in the prevention of incident heart failure
  4. Hypertension, 2025 -- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults
  5. PMC, 2025 -- A systematic review and meta-analysis of the association between cardiovascular health determined by life's essential 8 and risk of mortality and major non-communicable diseases
  6. Frontiers in Medicine — Embedding structural and social determinants of cardiovascular health into medical education: a systematic review of pedagogical frameworks
  7. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Hypertension
  8. A systematic review and meta-analysis of the association between cardiovascular health determined by life's essential 8 and risk of mortality and major non-communicable diseases - PMC
  9. Produce Prescription Subsidy for Patients With Diabetes: A Pragmatic Randomized Clinical Trial | Trial Resources | JAMA Internal Medicine | JAMA Network

Original Source(s)

Related Content